These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17845559)

  • 21. T-regulatory cells in chronic rejection versus stable grafts.
    Al-Wedaie F; Farid E; Tabbara K; El-Agroudy AE; Al-Ghareeb SM
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():170-6. PubMed ID: 25894149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical rejection and persistent immune regulation in kidney transplant patients.
    Hendrikx TK; Klepper M; Ijzermans J; Weimar W; Baan CC
    Transpl Immunol; 2009 Jul; 21(3):129-35. PubMed ID: 19398001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection.
    Veronese F; Rotman S; Smith RN; Pelle TD; Farrell ML; Kawai T; Benedict Cosimi A; Colvin RB
    Am J Transplant; 2007 Apr; 7(4):914-22. PubMed ID: 17286616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates.
    Torrealba JR; Katayama M; Fechner JH; Jankowska-Gan E; Kusaka S; Xu Q; Schultz JM; Oberley TD; Hu H; Hamawy MM; Jonker M; Wubben J; Doxiadis G; Bontrop R; Burlingham WJ; Knechtle SJ
    J Immunol; 2004 May; 172(9):5753-64. PubMed ID: 15100322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The number of regulatory T cells in transbronchial lung allograft biopsies is related to FoxP3 mRNA levels in bronchoalveolar lavage fluid and to the degree of acute cellular rejection.
    Krustrup D; Madsen CB; Iversen M; Engelholm L; Ryder LP; Andersen CB
    Transpl Immunol; 2013 Dec; 29(1-4):71-5. PubMed ID: 23969200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates.
    Bashuda H; Kimikawa M; Seino K; Kato Y; Ono F; Shimizu A; Yagita H; Teraoka S; Okumura K
    J Clin Invest; 2005 Jul; 115(7):1896-902. PubMed ID: 15951837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation.
    Wang X; Wang W; Xu J; Le Q
    Transplant Proc; 2013 Mar; 45(2):528-37. PubMed ID: 23267787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients.
    Stenard F; Nguyen C; Cox K; Kambham N; Umetsu DT; Krams SM; Esquivel CO; Martinez OM
    Pediatr Transplant; 2009 Feb; 13(1):70-80. PubMed ID: 18331536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.
    Urbanellis P; Shyu W; Khattar R; Wang J; Zakharova A; He W; Sadozai H; Amir AZ; Shalev I; Phillips MJ; Adeyi O; Ross H; Grant D; Levy GA; Chruscinski A
    Immunology; 2015 Jan; 144(1):91-106. PubMed ID: 24990517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of the ratio between FOXP3 positive regulatory T cell and interleukin-17 secreting cell in renal allograft biopsies with acute T-cell-mediated rejection.
    Chung BH; Oh HJ; Piao SG; Hwang HS; Sun IO; Choi SR; Park HS; Choi BS; Choi YJ; Park CW; Kim YS; Cho ML; Yang CW
    Immunology; 2012 Jul; 136(3):344-51. PubMed ID: 22444300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absolute of CD4(+)CD25(+)FOXP3(+) regulatory T-cell count rather than its ratio in peripheral blood is related to long-term survival of renal allografts.
    Liu L; Deng S; Teng L; Fu Q; Wang C; He X
    Transplant Proc; 2012 Jan; 44(1):284-6. PubMed ID: 22310634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Foxp3+ T cells in peripheral blood of renal transplant recipients and clinical correlations.
    Lin WX; Christiansen D; Fu LL; Roberts MA; Sandrin MS; Ierino FL
    Nephrology (Carlton); 2012 May; 17(4):415-22. PubMed ID: 22308996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indoleamine 2,3-dioxygenase and foxp3 expression in skin rejection of human hand allografts.
    Hautz T; Brandacher G; Zelger B; Müller HG; Lee AW; Fuchs D; Margreiter R; Schneeberger S
    Transplant Proc; 2009 Mar; 41(2):509-12. PubMed ID: 19328914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft.
    Poirier N; Dilek N; Mary C; Ville S; Coulon F; Branchereau J; Tillou X; Charpy V; Pengam S; Nerriere-Daguin V; Hervouet J; Minault D; Le Bas-Bernardet S; Renaudin K; Vanhove B; Blancho G
    Am J Transplant; 2015 Jan; 15(1):88-100. PubMed ID: 25488654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell phenotype in protocol renal biopsy from transplant recipients treated with belatacept-mediated co-stimulatory blockade.
    Grimbert P; Audard V; Diet C; Matignon M; Plonquet A; Mansour H; Desvaux D; Durrbach A; Cohen JL; Lang P
    Nephrol Dial Transplant; 2011 Mar; 26(3):1087-93. PubMed ID: 20667993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.
    Fourtounas C; Dousdampanis P; Sakellaraki P; Rodi M; Georgakopoulos T; Vlachojannis JG; Mouzaki A
    Am J Nephrol; 2010; 32(1):1-9. PubMed ID: 20484893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged renal allograft survival by donor interleukin-6 deficiency: association with decreased alloantibodies and increased intragraft T regulatory cells.
    Wang H; Guan Q; Lan Z; Li S; Ge W; Chen H; Nguan CY; Du C
    Am J Physiol Renal Physiol; 2012 Jan; 302(2):F276-83. PubMed ID: 22031852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FOXP3+ regulatory T-cells in renal allografts: correlation with long-term graft function and acute rejection.
    Kollins D; Stoelcker B; Hoffmann U; Bergler T; Reinhold S; Banas MC; Rümmele P; Farkas S; Krämer BK; Banas B
    Clin Nephrol; 2011 Feb; 75(2):91-100. PubMed ID: 21255537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.